Baldness: the molecule that 'awakens' dormant follicles and could regenerate hair growth
Researchers at the University of California have identified a molecule (PP405) that can reactivate inactive hair follicles, showing promising results in clinical trials for men experiencing hair loss.
"Hold on, this is what we were waiting for": Are the new clinical trials against baldness the dreamed revolution?
The clinical trials for PP405, a drug financed by Google aimed at treating androgenetic alopecia, have generated excitement among many men facing hair loss, though experts caution it is not yet a replacement for hair transplants.